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ABSTRACT 
To address the challenge of accurate, low cost and robust biosensors for diabetes management 
and early detection of diabetes complications, we have developed novel, robust sensing 
chemistry (or receptors) for electrochemical POC biosensors. The biosensors have been 
developed for the bio-markers associated with diabetes management such as glycated 
hemoglobin (HbA1c), glycated albumin, glucose, biomarkers associated with diabetes 
complications such as microalbuminuria, urine creatinine and albumin-to-creatinine ratio 
(ACR) and biomarkers associated with anemia and malnutrition conditions such as hemoglobin 
and serum albumin. 
 
For hemoglobin detection, a new POC biosensing technique has been developed based on Aza-
heterocyclic chemicals. The repeatability and accuracy of the biosensor have been tested on 
real pathology samples. The glycated form of hemoglobin, called glycated hemoglobin or 
HbA1c, is the gold standard test in diabetes management as it gives the 90-days average blood 
glucose value. We demonstrate a simple method for electrochemical detection of HbA1c by 
combining boronic affinity principle along with aza-heterocyclic receptors. The technique has 
been verified on the real clinical patient samples. 
 
Albumin is the most abundant protein in the human blood. Human serum albumin (HSA) is 
either alone or an associative biomarker in several chronic diseases like necrosis, nephrosis, 
hepatitis, malnutrition, arthritis, immune disorders, cancer, diabetes and in some severe 
infections. In pathology laboratories, the serum albumin is usually tested on serum samples 
and not in whole blood samples. Since albumin is not a metalloprotein, it is very difficult to 
develop electrochemical POC biosensor. We have developed a novel technique for the 
electrochemical detection of serum albumin in whole blood samples, by exploiting its binding 
property with redox active copper salts. The accuracy of technique has been verified on both 
real human blood plasma as well as whole blood samples.  Glycated albumin, which is the 
glycated form of serum albumin, is emerging as a novel biomarker for diabetes management, 
as it gives the average blood glucose value of 15-20 days. It is also extremely useful in chronic 
kidney disease patients and patients with hemoglobinopathies where HbA1c can give the 
erroneous results. By combining the copper chemistry along with boronic affinity principle, 
we present the first ever demonstration of glycated albumin sensing.  
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Instant blood glucose monitoring is an integral part of diabetes management. Most of the 
glucometers available in the market are based on glucose oxidase enzyme. We have 
demonstrated a low cost non-enzymatic electrochemical technique for blood glucose detection 
using alkaline methylene blue chemistry. The accuracy of the technique has been verified on 
real human blood plasma samples. Glucometer is one of the most easily available POC 
biosensor and a useful tool for diabetes population. India has second largest diabetes population 
in the world. To analyze the accuracy of the POC glucometers which are available in Indian 
market, a comprehensive study was conducted. The results were compared with clinical 
accuracy guidelines using exhaustive statistical analysis techniques. The shortcoming of the 
commercial glucometers are elucidated, regarding different international standards. 
	
Diabetic nephropathy is one of the major diabetes complications and is the primary cause of 
chronic kidney disease (CKD). The presence of albumin in urine is a well-established 
biomarker for the early detection of diabetic nephropathy. We have developed a technique for 
electrochemical detection of microalbuminuria for point of care applications by exploring the 
binding property of human albumin with electrochemically active molecules like copper and 
hemin. Methylene blue mediated sensing technique has also been proposed.  Urine Albumin-
to creatinine ratio (ACR) is another variant of the microalbumuria test that can be done any 
time and does not suffer from the dilution factor of urine. Iron binding property of creatinine 
is exploited to develop creatinine biosensor, thus enabling POC ACR tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
